Antonella Santuccione Chadha shares her thoughts on being nominated for the Veuve Clicquot Bold Woman Award 2022

In March of this year, it was announced that Dr. Antonella Santuccione Chadha, the CEO of Women’s Brain Project, was one of the women nominated for the Veuve Clicquot Bold Woman Award Switzerland 2022 which will be announced on September 1st, 2022 in Zürich, Switzerland.

Dr. Antonella Santuccione Chadha stands between the other finalists.

 

It’s an honour to be nominated for such an award and in the video below you can learn from Dr. Antontella Santuccione Chadha exactly how she feels about being nominated.

We are looking forward to the announcement on September 1st, and will be celebrating whoever shall be declared the winner. Strong women leaders changing the world around them as the women who are nominated are doing every day, is such an inspiration for each and every one of us. As we at the Women’s Brain Project continue working to study and close the sex and gender gap existing in brain and mental diseases, we will look to these women as our motivation that change in the world is possible.

 

Our mission could not be achieved without our team, our many supporters, and all those who donate. If you would like to get involved and become a member, or donate to the work that is done here at the Women’s Brain Project, we’d be grateful for your involvement and support as we continue to change the world together.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Return Home

Make a Donation

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.